News

News

Voiant Acquires Voxeleron to Expand Ophthalmic Clinical Research with AI Technology

  • April 15, 2025

WALTHAM, Mass. / PRNewswire-PRWeb Voiant, a leader in clinical trial imaging solutions, today is announcing the acquisition of Voxeleron, a…

News

Voiant Delivers Primary Endpoints in Two New Drug Approvals for Colorectal Cancer and Glioma Following Successful FDA Inspections

  • February 18, 2025

WALTHAM, Mass. / PRNewswire-PRWeb Voiant, the industry’s leading AI-driven clinical trial imaging solution provider, is proud to announce that the…

News

Voiant Boosts Ophthalmology Imaging Services, Doubling Reader Capacity

  • June 3, 2024

WALTHAM, Mass. / PRNewswire-PRWeb Voiant, a leader in clinical trial imaging solutions, today announced significant enhancements to its ophthalmology imaging…

News

Voiant’s Commitment to Quality Affirmed by FDA Inspection with No Findings Raised

  • May 20, 2024

WALTHAM, Mass. / PRNewswire-PRWeb Voiant, a leader in clinical trial imaging solutions, is proud to announce the successful completion of…

News

MedQIA, WorldCare Clinical and DARC Merge to Form Voiant, LLC: A New Paradigm in AI-Driven Clinical Trial Imaging

  • September 7, 2023

WALTHAM, Mass. / PRNewswire-PRWeb Today, industry leaders MedQIA, WorldCare Clinical and DARC are excited to announce their merger and the…